Sung Lee
Director of Finance/CFO en VIR BIOTECHNOLOGY, INC. .
Fortuna: 1 M $ al 31/03/2024
Perfil
Sung H.
Lee is currently the Chief Financial Officer, Secretary & Executive VP at Vir Biotechnology, Inc. He previously held positions as Vice President-Investor Relations at Gilead Sciences, Inc. from 2005 to 2019, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, and Chief Financial Officer at MorphoSys AG from 2021 to 2023.
Mr. Lee holds a graduate degree from the University of Southern California and an undergraduate degree from the University of California, Irvine.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
VIR BIOTECHNOLOGY, INC.
0.07% | 27/03/2024 | 100 492 ( 0.07% ) | 1 M $ | 31/03/2024 |
Cargos activos de Sung Lee
| Empresas | Cargo | Inicio |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Director of Finance/CFO | 27/03/2023 |
Antiguos cargos conocidos de Sung Lee.
| Empresas | Cargo | Fin |
|---|---|---|
| MORPHOSYS AG | Director of Finance/CFO | 17/03/2023 |
| SANGAMO THERAPEUTICS, INC. | Director of Finance/CFO | 01/02/2021 |
| GILEAD SCIENCES, INC. | Investor Relations Contact | 31/10/2019 |
Formación de Sung Lee.
| University of Southern California | Graduate Degree |
| University of California, Irvine | Undergraduate Degree |
Experiencias
Funciones ocupadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 4 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| MORPHOSYS AG | Health Technology |
| VIR BIOTECHNOLOGY, INC. | Health Technology |
- Bolsa de valores
- Insiders
- Sung Lee
